Corbin Capital Partners, L.P.
Clone Performance
Aug 2023–Jul 2025 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 96% of reported value on average across 7 quarters.Corbin Capital Partners, L.P. has stopped filing, so the simulation ends in Jul 2025 — where its last reported portfolio went stale — rather than trading that portfolio forward to today. Past performance does not predict future results.
Portfolio Concentration
13 tracked positions · as of Dec 31, 2024 · Δ vs Sep 30, 2024Portfolio Trend
Sector Breakdown
As of Dec 31, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 60.1% | $6,421,240 |
| Healthcare | 26.0% | $2,783,495 |
| Industrials | 13.9% | $1,485,850 |
| Basic Materials | 0.0% | $0 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CORZ | Core Scientific, Inc./tx | −625,318 | 402,013 | $5,648,282 | |
| EVLV | Evolv Technologies Holdings, Inc. | −259,000 | 353,000 | $1,394,350 | |
| ABUS | Arbutus Biopharma Corp | −170,817 | 682,487 | $2,231,732 | |
| ROIV | Roivant Sciences Ltd. | −104,245 | 46,641 | $551,763 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NVTS | Navitas Semiconductor Corp | 216,515 | $772,958 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CORZ |
Core Scientific, Inc./tx
Technology
|
Reduced | 402,013 | $5,648,282 | 52.83% | |
| ABUS |
Arbutus Biopharma Corp
Healthcare
|
Reduced | 682,487 | $2,231,732 | 20.88% | |
| EVLV |
Evolv Technologies Holdings, Inc.
Industrials
|
Reduced | 353,000 | $1,394,350 | 13.04% | |
| NVTS |
Navitas Semiconductor Corp
Technology
|
NEW | 216,515 | $772,958 | 7.23% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 46,641 | $551,763 | 5.16% | |
| HTZ |
Hertz Global Holdings, Inc
Industrials
|
Held | 25,000 | $91,500 | 0.86% | |
| BNAI |
Brand Engagement Network Inc.
Technology
|
Held | 49,363 | $0 | 0.00% | |
| DAVE |
Dave Inc./DE
Technology
|
Held | 966,705 | $0 | 0.00% | |
| PGY |
Pagaya Technologies Ltd.
Technology
|
Held | 65,389 | $0 | 0.00% | |
| TVGN |
Tevogen Inc.
Healthcare
|
Held | 1,160,000 | $0 | 0.00% | |
| NB |
Niocorp Developments Ltd
Basic Materials
|
Held | 497,987 | $0 | 0.00% | |
| RZLV |
Rezolve Ai PLC
Technology
|
Held | 139,070 | $0 | 0.00% | |
| DRTS |
Alpha Tau Medical Ltd.
Healthcare
|
Held | 960,479 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.